1. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
   Ping-Chih Hsu et al, 2019, International Journal of Molecular Sciences CrossRef
2. Investigation of apoptotic effects of Cucurbitacin D, I, and E mediated by Bax/Bcl‐xL, caspase‐3/9, and oxidative stress modulators in HepG2 cell line
   Muhammed Mehdi Üremiş et al, 2024, Drug Development Research CrossRef
3. Use of cucurbitacins for lung cancer research and therapy
   Min Liu et al, 2021, Cancer Chemotherapy and Pharmacology CrossRef
4. Forced Overexpression of Signal Transducer and Activator of Transcription 3 (STAT3) Activates Yes-Associated Protein (YAP) Expression and Increases the Invasion and Proliferation Abilities of Small Cell Lung Cancer (SCLC) Cells
   Ping-Chih Hsu et al, 2022, Biomedicines CrossRef
5. Structure-Activity Relationship Insight of Naturally Occurring Bioactive Molecules and Their Derivatives Against Non-Small Cell Lung Cancer: A Comprehensive Review
   Subham Das et al, 2022, Current Medicinal Chemistry CrossRef
6. MicroRNA‑608 sensitizes non‑small cell lung cancer cells to cisplatin by targeting TEAD2
   Yanli Wang et al, 2019, Molecular Medicine Reports CrossRef
7. The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC)
   Ping-Chih Hsu et al, 2020, Cancers CrossRef